Mr. Johnson currently serves as our Chief Executive Officer and President. He served as our President and Chief Operating Officer from June 2010 until June 2017. He is responsible for providing effective leadership, direction in planning, oversight of all business development and operational and technology functions, and managing and directing all corporate activities. Prior to June 2010, he served as Chief Operating Officer and Executive Vice President of Business Development since April 2008, managing the delivery and execution of all operational activities including sales, marketing, professional services and clinical services and support. Mr. Johnson joined OmniComm as Senior Vice President of Business Development in September 2006 and was initially responsible for global sales and marketing and client services and support. Prior to joining OmniComm Systems, he spent seven years managing business development for the Oracle Clinical Applications group for the East Coast. He has more than 25 years of industry experience specific to clinical trials and electronic data capture (EDC), having held various positions of increasing responsibility for Oracle, PHT Corp., Clinical Data Solution and Pfizer Pharmaceuticals. Mr. Johnson received his B.S. in Microbiology from the University of Massachusetts Amherst.
Mr. Vickers joined OmniComm in October 2011 as the Vice President of Finance. In October 2012, he was promoted to Chief Financial Officer. Prior to joining OmniComm, Mr. Vickers was with Ocwen Financial Corporation, a publicly traded diversified financial services holding company, where he served in positions of increasing responsibility, most recently as Director, Servicing Operations. Previously Mr. Vickers was Vice President, Operations for S&J and Vice President, Financial Operations for Precision Response Corporation. Mr. Vickers has undergraduate degrees in Finance and Accounting and a Master of Taxation from Florida Atlantic University, an MBA from the University of Miami and is a Chartered Financial Analyst Charterholder.
Mr. Fontenault has served as the Company’s Chief Operating Officer since June 2017. He served as our Senior Vice President of Operations from October 2014 until June 2017. A clinical data operations and data systems executive, he brings more than 25 years of pharmaceutical industry experience. Prior to joining OmniComm, Mr. Fontenault was Vice President, Operations at ER Squared, providing strategic eClinical business process and technology change management and adoption services to large and small-sized sponsors and CROs. Prior to ER Squared, Mr. Fontenault was Executive Director and Global Head of Clinical Data Management and Technology at Kendle International (INC Research), where he was responsible for a staff of 500 in 13 locations worldwide. Prior to Kendle, Mr. Fontenault held positions of increasing responsibility at Bayer.
Mr. Howells has served as the Company’s Chief Technology Officer since June 2017. He served as our Senior Vice President of Development from April 2012 until June 2017. He joined OmniComm in January 2011, with responsibility for the development and forward direction of the company’s products. Mr. Howells has over 20 years of experience in building and implementing clinical research applications, including 5 years as head of development for Oracle’s pharmaceutical application suite and 5 years as head of development for Medidata Solutions. This encompasses applications for clinical data management, EDC, medical dictionary coding, safety, trial planning and trial budgeting. Mr. Howells has a degree in physics from Oxford University, England.
Dr. van der Post has served as the Company’s Chief Commercial Officer since June 2017. He served as our Senior Vice President of Business Development from June 2013 until June 2017. He has been working in both the preclinical and clinical development arena for more than 14 years. Prior to joining OmniComm, he worked for Oracle’s Health Sciences Global Business Unit as well as Medidata Solutions. He obtained his Ph.D. from the University of Liverpool (UK) and his Master of Science degree from Salford University (UK). He currently leads OmniComm’s global sales and marketing teams.
Dr. Rollinger is Managing Director of OmniComm Europe, located in Bonn, Germany. She has oversight of all business activities of this entity. Before joining OmniComm, she was Director Clinical Services and Senior Consultant at DATATRAK. Prior to that, she served as Project Manager, CRA and Sales Representative at Medifacts International Medical Consultants, Padcom Clinical Research, Dolorgiet Pharmaceuticals and Spitzner Pharmaceuticals. Dr. Rollinger received a Ph.D. from Rheinische Friedrich-Wilhelms-Universität Bonn in Biology and Biochemistry. She has more than 25 years of experience in the pharmaceutical industry with a focus on clinical trial management and EDC.
Ken Light is the Executive Vice President of Corporate Strategy since June 2017. Previously, he was the Executive Vice President of Operations and Professional Services at OmniComm. Prior to joining OmniComm, Mr. Light was a Solutions Partner at BusinessEdge Solutions, Inc. where he oversaw the delivery of technology, strategy and process improvement services for pharmaceutical and life sciences companies. Prior to that, he was Practice Director, Life Sciences Consulting for Oracle Corporation, where he oversaw clinical software implementation activities for major pharmaceutical and life science organizations. Before joining Oracle, he was Practice Director, Clinical Technology for First Consulting Group. Mr. Light received a B.S. from SUNY Binghamton and an M.S., Computer Science from Fairleigh Dickinson University and has delivered a multitude of educational industry presentations at meetings such as the DIA, EDC and Beyond, ACRP and the eClinical Forum.